Table 3.
Group | ALT (U/L) | AST (U/L) | T-BIL (μmol/L) |
---|---|---|---|
C | 49.33 ± 2.44 | 307.80 ± 49.36 | 1.00 ± 0.49 |
M | 49.00 ± 6.54 | 275.00 ± 36.40 | 0.91 ± 0.30 |
A | 54.62 ± 11.16 | 253.88 ± 39.15 | 1.33 ± 0.32 |
AR-L | 50.83 ± 12.30 | 295.77 ± 54.13 | 0.87 ± 0.76 |
AR-H | 51.44 ± 10.28 | 284.10 ± 42.75 | 1.27 ± 1.14 |
RSG-L | 52.70 ± 10.13 | 301.45 ± 62.84 | 1.10 ± 0.52 |
RSG-H | 93.67 ± 13.94∗∗ | 362.11 ± 46.89∗∗ | 3.50 ± 1.06∗∗ |
C, control; M, model; A, allopurinol; AR-L, low dose of AR; AR-H, high dose of AR; RSG-L, low dose of RSG; RSG-H, high dose of RSG; ALT, alanine aminotransferase; AST, aspartate aminotransferase; T-BIL, total bilirubin. ∗∗Significantly different from those of the model group at the level of P < 0.01.